2020
DOI: 10.1007/s11255-020-02474-2
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in understanding the role of hypoxia-inducible factor 1α in renal fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 69 publications
1
13
0
Order By: Relevance
“…HIF-1α is a transcription factor that is widely present in the cytoplasm and nucleus and can indicate the degree of hypoxia. 37 The trend of the HIF-1α score was similar to that of the HE score of renal tubular injury. This also reflects the direct consequence of hypoxia caused by reduced perfusion.…”
Section: Discussionsupporting
confidence: 54%
“…HIF-1α is a transcription factor that is widely present in the cytoplasm and nucleus and can indicate the degree of hypoxia. 37 The trend of the HIF-1α score was similar to that of the HE score of renal tubular injury. This also reflects the direct consequence of hypoxia caused by reduced perfusion.…”
Section: Discussionsupporting
confidence: 54%
“…Rajendran et al [49] found that in IR-induced AKI model of mouse, HIF-1 activated by inhibiting the PHD2 in RTECs could improve renal in ammation as well as renal failure and block the transition from AKI to CKD. On the other hand, there are also some evidences indicating that in the context of hypoxia, HIF-1α could induce EMT of RTECs and ECM deposition to promote the occurrence of renal brosis [3,15]. For example, Higgins et al [50] found that in the models of mice with UUO-induced renal injury and proximal RTECs with hypoxia-induced injury in vitro, HIF-1α could promote the EMT of RTECs while genetic ablation of HIF-1α in RTECs could inhibit the development of renal tubulointerstitial brosis, which might be related to the decrease of interstitial collagen deposition, in ammatory cell in ltration and broblast-speci c protein-1-expressing (FSP-1-expressing) interstitial cells.…”
Section: Discussionmentioning
confidence: 99%
“…In hypoxia, the activity of PHDs is inhibited to prevent the hydroxylation and hydrolysis of HIF-1α, resulting in the accumulation of HIF-1α. HIF-1α interacts with HIF-1β to form a dimer HIF-1 and then HIF-1 binds to hypoxia response elements (HRE) in the regulatory region of the nucleus to activate downstream target genes, such as Erythropoietin (EPO), vascular endothelial growth factor (VEGF), Twist and B lymphoma Mo-MLV insertion region homolog 1 (Bmi1), eventually inducing related hypoxia responses like angiogenesis, cell proliferation and apoptosis [3,13,[15][16][17]. At present, more and more studies have found that HIF-1α may be one of the key regulators of renal tubular hypoxia injury and renal brosis [3,15,17,18].…”
Section: Introductionmentioning
confidence: 99%
“…Fourth, we did not consider the use of erythropoiesis-stimulating agents during the follow-up period. As to treatment contents, recent studies have revealed that hypoxia-inducible factor-prolyl hydroxylase inhibitors might suppress tubulointerstitial fibrosis by suppressing the transformation of renal interstitial fibroblasts in addition to enhancing erythropoiesis [ 27 , 28 ]. Furthermore, some previous studies revealed that sodium-glucose cotransporter 2 inhibitors might improve tubulointerstitial hypoxia, allowing fibroblasts to resume erythropoietin production [ 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%